Functionalized Periodic Mesoporous Silica Nanoparticles for Inhibiting the Progression of Atherosclerosis by Targeting Low-Density Lipoprotein Cholesterol
Atherosclerotic disease is a substantial global burden, and existing treatments, such as statins, are recommended to lower low-density lipoprotein cholesterol (LDL-C) levels and inhibit the progression of atherosclerosis. However, side effects, including gastrointestinal unease, potential harm to th...
Saved in:
Main Authors: | Hao Jin (Author), Wenbin Lu (Author), Yahao Zhang (Author), Yong Wu (Author), Jiandong Ding (Author), I. R. Chiara Villamil Orion (Author), Cihui Liu (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Monocyte/high-density lipoprotein cholesterol, neutrophil/high-density lipoprotein cholesterol, and lymphocyte/high-density lipoprotein cholesterol ratios as new inflammatory markers in rosacea
by: Bülent Nuri Kalaycı
Published: (2023) -
Candidate genetic analysis of plasma high-density lipoprotein-cholesterol and severity of coronary atherosclerosis
by: Gotto Antonio M, et al.
Published: (2009) -
Hyaluronic Acid-Functionalized Mesoporous Silica Nanoparticles Loading Simvastatin for Targeted Therapy of Atherosclerosis
by: Kechen Song, et al.
Published: (2022) -
Inclisiran, Low-Density Lipoprotein Cholesterol and Lipoprotein (a)
by: Niki Katsiki, et al.
Published: (2023) -
Progress in Mesoporous Silica Nanoparticles as Drug Delivery Agents for Cancer Treatment
by: Eleen Dayana Mohamed Isa, et al.
Published: (2021)